EFFECTOR THERAPEUTICS INC - COM (EFTR)

CUSIP: 28202V108

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COM
Total 13F shares
24,109,298
Share change
+1,636,234
Total reported value
$33,849,146
Price per share
$1.42
Number of holders
22
Value change
+$2,203,070
Number of buys
13
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 28202V108?
CUSIP 28202V108 identifies EFTR - EFFECTOR THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EFFECTOR THERAPEUTICS INC - COM (EFTR) as of Q2 2022

As of 30 Jun 2022, EFFECTOR THERAPEUTICS INC - COM (EFTR) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,109,298 shares. The largest 10 holders included SR ONE CAPITAL MANAGEMENT, LP, Abingworth LLP, Column Group LLC, SECTORAL ASSET MANAGEMENT INC, Parallel Advisors, LLC, Blackstone Inc., OUP Management Co., LLC, Evolution Capital Management LLC, VANGUARD GROUP INC, and NORGES BANK. This page lists 22 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.